BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26742305)

  • 1. Effect of Xinfeng capsule in the treatment of active rheumatoid arthritis: a randomized controlled trial.
    Wang Y; Liu J; Wang Y; Sun Y
    J Tradit Chin Med; 2015 Dec; 35(6):626-31. PubMed ID: 26742305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Xinfeng capsule in patients with rheumatoid arthritis: a multi-center parallel-group double-blind randomized controlled trial.
    Liu J; Wang Y; Huang C; Xu J; Li Z; Xu L; He L; Sun Y; Wang Y; Xu S; Zhao P; Mao T; Tan B; Zhu F; Zhang P; Fang L
    J Tradit Chin Med; 2015 Oct; 35(5):487-98. PubMed ID: 26591677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Xinfeng Capsule increases peripheral blood BTLA expression of CD19(+) and CD24(+) B cells and relieves oxidative stress damage to improve cardiac function of patients with rheumatoid arthritis].
    Sun Y; Liu J; Wan L; Wang F; Qi Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):93-6, 99. PubMed ID: 25575067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xinfeng Capsule Improved Blood Stasis State of Rheumatoid Arthritis Patients Based on Actl/NF-KB Signaling Pathway: Mechanism and Effects].
    Zhang PH; Liu J; Tan B; Wan L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Aug; 36(8):922-928. PubMed ID: 30640985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: study protocol of a multicenter randomized controlled trial.
    Liu J; Huang CB; Wang Y; Xu GQ; Cheng YY; Feng YX; Liu L; Qi YJ
    J Integr Med; 2013 Nov; 11(6):428-34. PubMed ID: 24299607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of xinfeng capsule to treat abarticular pathologic changes in patients with rheumatoid arthritis.
    Liu J; Cao Y; Huang C; Wang Y; Chen X; Zhang W; Wang G; Fan H; Ge Y; Chen R; Zong R; Qi Y; Sun Y; Liu Y; Wang F
    J Tradit Chin Med; 2014 Oct; 34(5):532-8. PubMed ID: 25417401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of immune inflammation-related proteins in serum of patients with rheumatoid arthritis and the regulatory effect of Xinfeng Capsule on cytokines].
    Zhang Y; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):439-445. PubMed ID: 35603652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial.
    Wan L; Liu J; Huang CB; Wang Y; Chen X; Zhang WD; Wang GZ; Fan HX; Ge Y; Chen RL; Cao YX; Zong RK; Liu TY
    Chin J Integr Med; 2016 Mar; 22(3):168-76. PubMed ID: 26818127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis.
    Liu W; Wu YH; Hu SY; Zhong CL; Gao ML; Liu DW; Wang HY; Chen MZ; Song YJ; Yang BZ; Zheng QS; Yao H; Qi XB; Li G
    Trials; 2016 Jul; 17():359. PubMed ID: 27465818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration of the mechanism of xinfeng capsule in the treatment of ankylosing spondylitis based on B and T lymphocyte attenuator and oxidative stress].
    Qi YJ; Liu J; Zheng L; Cao YX; Wan L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jan; 35(1):25-32. PubMed ID: 25790670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
    Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
    BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of xinfeng capsule on the cardiac function in patients with rheumatoid arthritis.
    Cao YX; Liu J; Zhu Y
    Chin J Integr Med; 2011 Oct; 17(10):738-43. PubMed ID: 22101697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Xinfeng Capsule on AS Patients and Their Serum Immunoglobulin Subtypes and Peripheral Lymphocyte Autophagy].
    Ye WF; Liu J; Wan L; Cao YX; Wang SH; Wang YL; Ruan LP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):310-6. PubMed ID: 27236888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Xinfeng capsule treatment on the number of BTLA(+)T cells and oxidative stress of patients with ankylosing spondylitis].
    Qi Y; Liu J; Zheng L; Cao Y; Wan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1084-9. PubMed ID: 25270214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors.
    Genovese MC; Fleischmann RM; Greenwald M; Satterwhite J; Veenhuizen M; Xie L; Berclaz PY; Myers S; Benichou O
    Ann Rheum Dis; 2013 Sep; 72(9):1461-8. PubMed ID: 23268367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Xinfeng Capsules promotes apoptosis of synovial fibroblasts and attenuates inflammation in rheumatoid arthritis by regulating lncRNA MAPKAPK5-AS1].
    Wen JT; Liu J; Wang X; Wang J
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6542-6548. PubMed ID: 34994147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis.
    Jani RH; Gupta R; Bhatia G; Rathi G; Ashok Kumar P; Sharma R; Kumar U; Gauri LA; Jadhav P; Bartakke G; Haridas V; Jain D; Mendiratta SK
    Int J Rheum Dis; 2016 Nov; 19(11):1157-1168. PubMed ID: 26176644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate.
    Genovese MC; Lee E; Satterwhite J; Veenhuizen M; Disch D; Berclaz PY; Myers S; Sides G; Benichou O
    Ann Rheum Dis; 2013 Sep; 72(9):1453-60. PubMed ID: 23599435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week-112 Efficacy and Safety Results of the Open-Label Long-Term Extension of a Phase III, Double-Blind, Randomized, Placebo-Controlled Trial.
    Bingham CO; Mendelsohn AM; Kim L; Xu Z; Leu J; Han C; Lo KH; Westhovens R; Weinblatt ME;
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1627-36. PubMed ID: 25623393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.